| 2002 |
ATP6V1G1 (G1 isoform) is a bona fide subunit of the V-ATPase complex: it co-immunoprecipitates with V-ATPase subunits c and A, and the G1-containing V-ATPase shows defined Km(ATP) and Vmax values. G1 is ubiquitously expressed and localizes to intracellular compartments but is not detectable in synaptic vesicles (unlike the G2 isoform). |
Co-immunoprecipitation, subcellular fractionation, electron microscopy, enzymatic kinetics, yeast complementation assay |
The Journal of biological chemistry |
High |
12133826
|
| 2005 |
ATP6V1G1 localizes to the apical pole of narrow and clear cells in the rat epididymis, co-distributing with other V-ATPase subunits, consistent with its role in active proton secretion at the apical membrane; it is distinct from the intracellular localization of ATP6V0A2. |
Immunohistochemistry with isoform-specific antibodies, subcellular localization in epithelial tissue sections |
Biology of reproduction |
Medium |
16192400
|
| 2014 |
RILP (Rab7 effector) directly interacts with the ATP6V1G1 subunit of V-ATPase. RILP controls ATP6V1G1 recruitment to late endosomal/lysosomal membranes and its stability: RILP promotes proteasomal degradation of ATP6V1G1 via ubiquitylation. Alterations in ATP6V1G1 expression impair V-ATPase activity. |
Yeast two-hybrid, co-immunoprecipitation, pulldown, ubiquitylation assay, proteasome inhibitor experiments, V-ATPase activity assay |
Journal of cell science |
High |
24762812
|
| 2014 |
RILP regulates V-ATPase activity through its specific interaction with the ATP6V1G1 subunit, controlling V1G1 localization and stability, thereby modulating V-ATPase assembly and function at endosomes and lysosomes. |
Summary/commentary of experimental data from PMID 24762812; confirmed by co-immunoprecipitation and functional assays |
Communicative & integrative biology |
Medium |
26843904
|
| 2015 |
ATP6V1G1 knockdown in glioblastoma neurospheres impairs sphere-forming ability, induces cell death, and decreases matrix invasion, phenocopied by V-ATPase inhibitor bafilomycin A1, establishing ATP6V1G1 as functionally required for V-ATPase-dependent GBM stem cell maintenance. |
siRNA knockdown, neurosphere formation assay, cell viability assay, invasion assay, pharmacological V-ATPase inhibition |
Oncotarget |
Medium |
26020805
|
| 2017 |
ATM kinase directly interacts with V-ATPase V1 subunits ATP6V1E1 and ATP6V1G1 (identified by yeast two-hybrid). ATM phosphorylates ATP6V1G1, which disrupts the E–G subunit dimerization required for V-ATPase assembly. Inhibition of ATM restores E–G dimerization, promotes V1–V0 domain assembly, and reacidifies lysosomes, thereby recovering lysosome/autophagy function. |
Yeast two-hybrid, co-immunoprecipitation, direct phosphorylation assay, lysosomal pH measurement, autophagy flux assay |
Nature chemical biology |
High |
28346404
|
| 2020 |
UBQLN2 physically interacts with ATP6V1G1 (in vitro binding assays show stronger binding of WT UBQLN2 than ALS/FTD mutants). UBQLN2 regulates the stability and expression of ATP6V1G1: UBQLN2 knockout reduces ATP6V1G1 protein levels and decreases its turnover, while WT UBQLN2 overexpression increases ATP6V1G1 biogenesis. Overexpression of ATP6V1G1 in UBQLN2 knockout cells rescues autophagosome acidification defects. |
In vitro protein interaction assay, immunoblot, proteomic analysis, siRNA/KO, overexpression rescue, autophagosome acidification assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
32513711
|
| 2020 |
ATP6V1G1-high glioblastoma stem cells release small extracellular vesicles that activate ERK1/2 signaling in recipient cells. The EVs from V1G1-high cells have a distinct miRNA profile, and V-ATPase inhibition in producer cells blocks the pro-oncogenic EV effects. Mechanistically, forced expression of MAPK-targeting miRNAs in recipient cells suppresses ERK activation downstream of V1G1-high EVs. |
EV isolation, miRNA profiling, ERK1/2 signaling assay, V-ATPase inhibitor (bafilomycin), miRNA overexpression, proliferation/motility assay |
Molecular cancer research : MCR |
Medium |
32753475
|
| 2021 |
Oxidized ATM in breast cancer-associated fibroblasts phosphorylates ATP6V1G1, impairing lysosomal acidification, which leads to autophagosome fusion with multivesicular bodies rather than lysosomes, facilitating exosome release. Knockdown of ATM or BNIP3 blocks this pathway. |
Phosphorylation assay, shRNA knockdown, lysosomal pH measurement, autophagosome/MVB trafficking assay, exosome release quantification |
Journal of extracellular vesicles |
Medium |
34545708
|
| 2021 |
RORα transcriptionally induces Atp6v1g1 expression in hepatocytes; hepatocyte-specific RORα deletion reduces lysosomal acidity (measured by LysoSensor), and RORα infusion increases lysosomal acidity. This demonstrates that RORα controls lysosomal V-ATPase function through regulation of ATP6V1G1 transcription. |
Hepatocyte-specific knockout mouse, adenoviral overexpression, LysoSensor lysosomal pH measurement, gene expression analysis |
Hepatology communications |
Medium |
34558854
|
| 2024 |
pH neutralization of late endosomes by LLOMe increases assembly (recruitment) of V1G1 (ATP6V1G1) onto endosomal membranes. Increased V1G1 assembly stabilizes GTP-bound Rab7 via its known interactor RILP, leading to Rab7 hyperactivation, disrupted tubulation, and impaired mannose-6-phosphate receptor recycling. This defines a V-ATPase–RILP–Rab7 pathway for controlling late endosomal pH and function. |
Live-cell imaging, immunofluorescence, pharmacological pH neutralization (LLOMe, NH4Cl), expression of Rab7 mutants, functional trafficking assays |
Journal of cell science |
Medium |
38578235
|
| 2024 |
PD patient-derived plasma exosomes decrease ATP6V1G1 expression in microglia, impairing lysosomal acidification and causing accumulation of abnormally swollen lysosomes with reduced cathepsin activity, leading to α-synuclein accumulation. Lentiviral overexpression of ATP6V1G1 in the brain of MPTP-treated mice restores lysosomal function and confers neuroprotection. |
siRNA knockdown, lentiviral overexpression, LysoSensor pH measurement, immunofluorescence, western blotting, MPTP mouse model, behavioral assays |
CNS neuroscience & therapeutics |
Medium |
38702933
|
| 2025 |
FTO (m6A demethylase) promotes ATP6V1G1 expression in an m6A-dependent manner downstream of TLR7-MyD88 signaling in B cells. FTO deficiency reduces ATP6V1G1-mediated V-ATPase activity, impairing lysosomal autophagy, causing accumulation of damaged mitochondria with reduced oxidative phosphorylation and elevated ROS, which limits age-associated B cell (ABC) differentiation. |
FTO knockout/overexpression, m6A modification analysis, V-ATPase activity assay, lysosomal autophagy assay, mitochondrial function measurement, B cell differentiation assay, lupus mouse model |
Science translational medicine |
Medium |
41191778
|
| 2026 |
Heart-specific knockout of ATP6V1G1 in mice causes V-ATPase disassembly, inhibits proton-pumping activity, impairs endo/lysosomal acidification, and blocks autophagy at the autophagosome-lysosome fusion step, demonstrating an essential role for ATP6V1G1 in cardiac V-ATPase assembly and autophagic flux in vivo. |
Heart-specific knockout mouse, subcellular fractionation, immunoprecipitation, immunofluorescence, proximity ligation assay, colorimetric proton-pumping assay, autophagy flux assay |
Autophagy |
High |
41432243
|